N F Voelkel
Overview
Explore the profile of N F Voelkel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
197
Citations
5193
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Happe C, de Raaf M, Rol N, Schalij I, Vonk-Noordegraaf A, Westerhof N, et al.
Am J Physiol Lung Cell Mol Physiol
. 2016 Apr;
310(11):L1088-97.
PMID: 27036867
The SU5416 + hypoxia (SuHx) rat model is a commonly used model of severe pulmonary arterial hypertension. While it is known that exposure to hypoxia can be replaced by another...
2.
Happe C, Szulcek R, Voelkel N, Bogaard H
Vascul Pharmacol
. 2016 Jan;
83:17-25.
PMID: 26804008
In pulmonary arterial hypertension (PAH) structural and functional abnormalities of the small lung vessels interact and lead to a progressive increase in pulmonary vascular resistance and right heart failure. A...
3.
Voelkel N, Gomez-Arroyo J
Int J Clin Pract Suppl
. 2011 Jul;
(172):1-2.
PMID: 21736674
No abstract available.
4.
Yasuo M, Mizuno S, Kraskauskas D, Bogaard H, Natarajan R, Cool C, et al.
Eur Respir J
. 2010 Jun;
37(4):775-83.
PMID: 20562128
The pathobiology of chronic obstructive pulmonary disease (COPD) is not completely understood. The aim of this study was to assess the expression of hypoxia inducible factor (HIF)-1α in lung tissue...
5.
Chen Y, Hanaoka M, Droma Y, Chen P, Voelkel N, Kubo K
Eur Respir J
. 2009 Nov;
35(4):904-12.
PMID: 19897563
We hypothesised that endothelin (ET)-1 plays an important role in the pathogenesis of emphysema. We attempted to apply ET-1 receptor antagonists to demonstrate and further elucidate the molecular pathogenesis pathways...
6.
Koff P, Jones R, Cashman J, Voelkel N, Vandivier R
Eur Respir J
. 2009 Jan;
33(5):1031-8.
PMID: 19129289
Self-management strategies improve a variety of health-related outcomes for patients with chronic obstructive pulmonary disease (COPD). These strategies, however, are primarily designed to improve chronic disease management and have not...
7.
Golpon H, Voelkel N
Curr Drug Targets
. 2006 Jun;
7(6):737-41.
PMID: 16787175
Pulmonary emphysema, a major component of chronic obstructive pulmonary diseases, is a highly prevalent progressive tissue-destructive disease, with no effective treatments. The interplay between inflammation, matrix proteolysis, oxidative stress and...
8.
Nicolls M, Taraseviciene-Stewart L, Rai P, Badesch D, Voelkel N
Eur Respir J
. 2005 Dec;
26(6):1110-8.
PMID: 16319344
The association between autoimmunity and pulmonary arterial hypertension (PAH) has been appreciated for >40 yrs, but how autoimmune injury might contribute to the pathogenesis of this disease has only been...
9.
Voelkel N, Agusti A
Pulm Pharmacol Ther
. 2004 Oct;
17(5):249-51.
PMID: 15477119
No abstract available.
10.
Voelkel N, Cool C
Eur Respir J Suppl
. 2003 Nov;
46:28s-32s.
PMID: 14621104
Chronic obstructive lung disease affects the entire lung, not just the airways. Although pulmonary hypertension (PH) has long been recognised in a subset of patients with COLD, the important pathophysiological...